Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.22.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 3,064 $ 2,772
Restricted cash 250 600
Accounts receivable, net of allowance for doubtful accounts of $72 and $275, respectively 6,158 8,028
Other current assets 2,694 2,722
Total current assets 12,166 14,122
Property and equipment, net 6,349 7,349
Other intangible assets, net 7,287 11,351
Goodwill 8,433 8,433
Operating lease right of use assets 4,032 4,384
Other long-term assets 160 42
Total assets 38,427 45,681
Current liabilities:    
Accounts payable 2,694 4,511
Accrued salary and bonus 3,024 3,161
Other accrued expenses 9,198 9,795
Current liabilities from discontinued operations 766 766
Total current liabilities 15,682 18,233
Contingent consideration 1,383 1,818
Operating lease liabilities, net of current portion 3,154 3,540
Line of credit 1,500
Note payable at fair value 7,942
Other long-term liabilities 4,648 4,637
Total liabilities 34,309 28,228
Commitments and contingencies (Note 11)
Preferred stock, $.01 par value; 5,000,000 shares authorized, 47,000 Series B issued and outstanding 46,536 46,536
Stockholders’ deficit:    
Common stock, $.01 par value; 100,000,000 shares authorized; 4,228,169 and 4,075,257 shares issued, respectively; 4,195,412 and 4,055,593 shares outstanding, respectively 403 402
Additional paid-in capital 186,106 184,404
Accumulated deficit (227,059) (212,116)
Treasury stock, at cost (32,757 and 19,664 shares, respectively) (1,868) (1,773)
Total stockholders’ deficit (42,418) (29,083)
Total liabilities and stockholders’ deficit (8,109) (855)
Total liabilities, preferred stock and stockholders’ deficit $ 38,427 $ 45,681